期刊文献+

KIR2DL4-IgFc融合蛋白基因真核细胞表达载体的克隆及鉴定分析 被引量:3

Construction and sequencing of the eukaryotic expression vector of human KIR2DL4-IgFc fusion protein gene from maternal decidual mononuclear cells
下载PDF
导出
摘要 目的 构建人KIR2DL4-IgFc段融合蛋白基因真核细胞表达载体。方法 用RT-PCR从孕妇蜕膜组织单个核细胞的总mRNA中逆转录扩增KIR2DL4胞外段cDNA,经Nhe I和Bam HI双酶切后,定向插入真核细胞表达载体CD51negl中,然后经酶切和测序鉴定。结果 限制性内切酶酶切和序列分析表明已成功构建CD51negl-KIR2DL4载体。结论 本研究成功构建KIR2DL4-IgFc融合蛋白真核细胞表达载体,为研究KIR2DL4与其配体之间的关系奠定了基础。 ve To construct eukaryotic expression vector of human KIR2DL4-IgFc fusion protein gene. Methods Total cell RNA was extracted from maternal decidual mononuclear cells and the cDNA was amplified by RT-PCR; the cDNA fragments were inserted into the eukaryotic expression vector CD51negl and the recombined plasmid was identified by restriction endonucleases digestion and sequencing. Re-sults After restriction endonucleases treatment and sequencing, it was confirmed that the CD51negl-KIR2DL4 had been constructed succes sfully. Conclusion The recombinant eukaryotic expression vector CD51negl-KIR2DLA was successfully constructed.
出处 《免疫学杂志》 CAS CSCD 北大核心 2002年第3期170-172,共3页 Immunological Journal
基金 国家自然科学基金资助项目(30070784)
关键词 KIR 融合蛋白 基因克隆 序列分析 KIR2DL4-IgFc 真核细胞表达载体 KIR fusion protein cloning DNA sequencing
  • 相关文献

参考文献1

二级参考文献2

共引文献7

同被引文献39

  • 1[1]Braud VM, Allan DS, McMichael AJ. Functions of nonclassical MHC and non- MHC-encoded class Ⅰ molecules[ J]. Curr Opin Immunol , 1999,11(1):100- 108.
  • 2[2]Trowsdale J . Genetic and functional relationships between MHC and NK receptor genes [ J]. Immunity , 2001,15 (3):363 - 374.
  • 3[3]Thellin O, Coumans B, Zorzi W, et al. Tolerance to the foeto-placental ‘ graft': ten ways to support a child for nine months[ J]. Curr Opin Immunol, 2000,12(6): 731 - 737.
  • 4[4]Ober C, Aldrich C, Rosinsky B, et al. HLA-G1 protein expression is not essential for fetal survival[ J ]. Placenta, 1998,19(2/3): 127 - 132.
  • 5[5]Fan L, Zhang X, Xu L, et al. Preliminary study on the expression of HLA-G mRNA in normal placenta and placenta with R SA after immunotherapy[J]. Transplant Proc, 1999,31(4):1 854-1 856.
  • 6[6]Bainbridge D,Ellis S,Le-Bouteiller P, et al. HLA-G remains a mystery[J]. Trends Immunol, 2001,22(10) :548 - 552.
  • 7[9]Carosella ED, Moreau P, Le-Maoult J, et al. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance[J].Adv Immunol, 2003,81:199 - 252.
  • 8[10]Ljunggren HG, Karre K. In search of the ‘ missing self':MHC molecules and NK cell recognition[J]. Immunol Today,1990,11(7):237-244.
  • 9[11]Cohen GB, Gandhi RT, Davis DM, et al. The selective downregulation of class Ⅰ major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells[J]. Immunity, 1999,10(6) :661 - 671.
  • 10[12]Schust DJ, Tortorella D, Ploegh HL. HLA-G and HLA-C at the feto-maternal interface: lessons learned from pathogenic viruses[J]. Semin Cancer biol, 1999,9(1):37-46.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部